NS · Healthcare

Rubicon Research Ltd (RUBICON)

Pharmaceuticals & Biotechnology

Rubicon Research Ltd (RUBICON) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $227.00B, P/E ratio is 120.61. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RUBICON

Market cap

$227.00B

P/E ratio

120.61

Rubicon Research Ltd (RUBICON) — FAQ

What is Rubicon Research Ltd's market cap?

Rubicon Research Ltd (RUBICON) has a reported market cap of $227.00B (data as of 2026-07-10).

What is RUBICON's P/E ratio?

The price-to-earnings (P/E) ratio for Rubicon Research Ltd (RUBICON) is 120.61 (data as of 2026-07-10).

Does Rubicon Research Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Rubicon Research Ltd (RUBICON). Check the MyAverix Finance app for the latest dividend data.

What sector is Rubicon Research Ltd in?

Rubicon Research Ltd (RUBICON) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is RUBICON listed on?

RUBICON is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)